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Abstract
Background: In China, ovine babesiosis is one of the most important tick-borne haemoparasitic diseases of small
ruminants. It has a significant economic impact, and several Babesia motasi-like isolates have been recently shown
to be responsible for ovine babesiosis in this country.
Methods: Full-length and C-terminal-truncated forms of the rap-1a61-1 gene of Babesia sp. BQ1 (Lintan) were
cloned into the pET-30a plasmid and subsequently expressed as His-fusion proteins. The resulting recombinant
RAP-1a proteins (rRAP-1a61-1 and rRAP-1a61-1/CT) were purified and evaluated as diagnostic antigens using
Western blot analysis and ELISA. The native Babesia sp. BQ1 (Lintan) RAP-1 protein was recognized using Western
blots and IFAT by antibodies that were raised in rabbits against rRAP-1a61-1/CT. The specificity, sensitivity and
positive threshold values for rRAP-1a61-1/CT in ELISA were evaluated.
Results: Cross-reactivity was observed between rRAP-1a61-1/CT and positive sera for Babesia sp. BQ1 (Lintan),
Babesia sp. BQ1 (Ningxian) and Babesia sp. Tianzhu isolates obtained from infected sheep. At one week post-
inoculation, a significant increase was observed in the amount of antibodies produced against RAP-1a, and
high levels of antibodies against RAP-1a were observed for 3 months (at 84 days p.i.). A total of 3198 serum
samples were collected from small ruminants in 54 different regions in 23 provinces of China. These samples
were tested using ELISA based on the rRAP-1a61-1/CT protein. The results indicated that the average positive
rate was 36.02 %.
Conclusions: The present study suggests that rRAP-1a61-1/CT might be a potential diagnostic antigen for
detecting several isolates of B. motasi-like parasites infection.
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Background
Ovine babesiosis is one of the most important tick-
borne diseases of small ruminants. This disease has been
described in many countries throughout Asia, Europe and
Africa [1]. A phylogenetic tree based on the sequence of
the 18S rRNA gene showed that Babesia species belong-
ing to the following four groups are responsible for
babesiosis in small ruminants: B. ovis, B. motasi which are
a European and a Chinese clade (B. motasi-like), and the
Babesia sp. Xinjiang and B. crassa [2–7]. In the B. motasi
Chinese clade (B. motasi-like), six Babesia isolates (Babe-
sia sp. BQ1 (Lintan), Babesia sp. BQ1 (Ningxian), Babesia
sp. Tianzhu, Babesia sp. Hebei, Babesia sp. Madang and
Babesia sp. Liaoning) have been recently reported in the
Gansu, Hebei and Liaoning provinces of China. These
isolates can be classified into one or more sub-groups ac-
cording to their phylogenetic relationships, which have
been reconstructed based on several (18S rRNA, ITS, 28S,
rap-1) phylogenetic markers [7–12].
Currently, the strategy for controlling babesiosis is based
on chemotherapy against either the vector or the parasite.
Several compounds are used, but mainly ivermectin is
used against ticks and imidocarb against Babesia. Several
new anti-Babesia drugs (Triclosan, Nerolidol, Artesunate
and Atovaquone) are also used to control and treat
babesiosis [13]. However, this strategy has many draw-
backs, such as drug-resistance, the presence of drug
metabolites in the milk and meat, and high toxicity to the
animals themselves. Optimal treatment methods, includ-
ing those with biological activity against ticks and vaccines
that target either the ticks or the parasites, have been
extensively studied. But only live attenuated vaccines are
currently used in some countries, and no producing or
testing recombinant or subunit vaccines have been avail-
able to prevent babesiosis so far [13–16].
Clinical symptoms of babesiosis usually include fever,
anemia, and hemoglobinuria and can lead to death in
severe cases, which become apparent when merozoites
from the Babesia invade and replicate within host eryth-
rocytes, resulting in detectable parasitemia [17]. During
the process of erythrocytic invasion, some of the pro-
teins, including apical membrane antigen-1 (AMA-1),
rhoptry-associated-protein-1 (RAP-1), and spherical
body proteins (SBP-1, 2, 3), are secreted by the apical
organelles (rhoptries, micronemes and dense granules).
Although the functions and implications of these pro-
teins for vaccines designed against Babesia infections
have been described mainly in B. bigemina and B. bovis,
these data may form a basis for developing a recombin-
ant vaccine against other Babesia infections [17].
RAP-1 is an immunogenic protein that is approximately
40–60 kDa in size. It is localized in rhoptries and has been
characterized in all Babesia species examined so far (B.
bovis, B. bigemina, B. divergens, B. canis, B. ovis, B.
motasi-like, B. orientalis and B. gibsoni) [12, 18–23]. RAP-
1 was detected at all asexual growth stages [24] and was
expressed during the sporozoite stage by a RAP-1 specific
antisera that was obtained from rabbits immunized to
neutralize the binding of sporozoites of B. bovis to eryth-
rocytes [25]. Moreover, the role of RAP-1 in the erythro-
cyte invasion process has been studied in vitro during
parasite adhesion to erythrocytes, and experiments have
been performed to study the inhibitory effect of RAP-1-
specific antibodies on growth and invasion [24–26].
Immunization with native and recombinant RAP-1 pro-
tein from B. bovis and B. bigemina also induced immunity
and protected animals upon challenge [27–29]. These
studies strongly support the notion that RAP-1 plays a
functional role in the biology and development of Babesia
parasites and represents a potential candidate for the de-
velopment of recombinant vaccines against babesiosis
[30–33].
Rap-1 was characterized and found to be present as
multiple gene copies that are arranged in a tandem, head
to tail manner in all Babesia species. In sheep Babesia
species, the rap-1 locus of the B. motasi-like gene is
similar to the locus of B. bigemina: in both species, three
different isoforms (rap-1a, rap-1b and rap-1c), 5 identi-
cal rap-1b copies and a single rap-1c located at end of
locus have been described [12, 34]. Two rap-1a classes
named rap-1a61 and rap-1a67 have been described, and
each class is represented by two close variants (rap-
1a61-1 and rap-1a61-2; rap-1a67-1 and rap-1a67-2) in
Babesia sp. BQ1 (Lintan) [34]. Polymorphisms were lim-
ited to three nucleotide positions in the rap-1a61 copies
(rap-1a61-1, -2, -3) and were found in the rap-1 locus of
Babesia sp. BQ1 (Lintan) (rap-1a61-1 and -2), Babesia
sp. BQ1 (Ningxian) and Babesia sp. Tianzhu (rap-1a61-
2 and -3) [12, 34]. According to a phylogenetic tree that
was constructed based on the rap-1 gene sequences, the
B. motasi-like group can be separated into two sub-
groups: one that consists Babesia sp. BQ1 (Lintan and
Ningxian) and Babesia sp. Tianzhu and another that
contains Babesia sp. Hebei [12].
The rap-1a gene has been found in all Babesia species
and shows highly conserved protein features (30–45 %
identity among species), suggesting that this gene plays
an important role in the RBC invasion process [35].
Moreover, RAP-1a, in Babesia has been widely used as a
vaccine candidate and diagnostic antigen [21, 29, 36, 37].
The expression, biological characterization and immuno-
genicity of RAP-1a in sheep Babesia species have not
been extensively studied. In the present study, we cloned
and expressed RAP-1a and then detected the presence
of antibodies directed against native and recombinant
forms of RAP-1a during the course of infection. To
evaluate the potential of using recombinant RAP-1a as a
diagnostic antigen, we compared the diagnostic potential
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of full-length and truncated C-terminal recombinant
Babesia sp. BQ1 (Lintan) RAP-1a proteins using via
Western blot analysis. We discuss our results in combin-
ation with the outcomes of previous studies.
Methods
Parasites
The original isolates of the B. motasi-like group, including
Babesia sp. BQ1 (Lintan), Babesia sp. BQ1 (Ningxian),
Babesia sp. Tianzhu and Babesia sp. Hebei, were obtained
from infected sheep and then cryopreserved in liquid
nitrogen at the Vector and Vector-borne Disease (VVBD)
Laboratory of the Lanzhou Veterinary Research Institute
(LVRI) (CAAS Lanzhou, China) [3, 4, 6].
Sera
Positive sera were obtained from five different breeds of
sheep (two “Tan mutton” Chinese sheep, including No.
3216 and 2007, and three “Vendean” French sheep, in-
cluding No. 3309, 3533 and 3446) that were infected
with Babesia sp. BQ1 (Lintan). Immune-positive sera
were obtained from sheep Nos. 08026, 08040 and 08020,
which were infected by Babesia sp. BQ1 (Ningxian),
Babesia sp. Tianzhu and Babesia sp. Hebei, respectively,
and immune-positive sera were obtained from sheep No.
3201, which was infected with Babesia sp. Xinjiang, as
previously described [38]. These serum samples were
used to evaluate cross-infection and antibody kinetics.
Positive sera from sheep that were experimentally in-
fected with Theileria luwenshuni, T. uilenbergi and Ana-
plasma ovis or bovine B. bovis and B. bigemina were
used as the controls to evaluate cross-reactivity.
Fifty serum samples were collected from five sheep (3–
12 wpi) that were experimentally infected with Babesia sp.
BQ1 (Lintan). In total, 141 sera and anticoagulated blood
samples were collected from sheep in the Xinjiang, Henan
and Gansu provinces of China. Genomic DNA was puri-
fied from blood samples and tested using specific PCR
primers, and 141 genomic DNA samples were found to be
specifically positive for Babesia sp. BQ1 (Lintan) in the
sequencing analysis (data not shown). The sera sam-
ples (n = 141) that corresponded to these genomic
DNA samples were selected as the positive serum
samples. A total of 191 sera were used as positive
samples to evaluate the sensitivity of the ELISA, and
a mixture of these sera was used as the positive con-
trol serum.
Sera were collected from 492 lambs that were pur-
chased from a Babesia-free region in Jingtai country
(Gansu province of China) from 2010 to 2015. After
nested PCR tests were performed, none of the samples
tested positive, and a mixture of these serum samples
was used as the negative control serum to evaluate the
specificity of the ELISA.
A total of 3198 serum samples were randomly col-
lected from clinically healthy sheep from 54 different
locations in 23 Chinese provinces between 2010 and
2015 (Fig. 1). All blood samples were collected in non-
anticoagulation tubes and transported to the laboratory
while on ice. The serum was then separated and stored
at -20 °C until further use.
Ethical approval
This study was approved by the Animal Ethics Commit-
tee of the Lanzhou Veterinary Research Institute at the
Chinese Academy of Agricultural Sciences. All animals
used in this study were handled in accordance with the
Animal Ethics Procedures and Guidelines of the People’s
Republic of China.
Cloning of the full-length and the C-terminal truncated
RAP-1a61-1 genes
Genomic DNA was extracted from infected blood sam-
ples obtained from sheep infected with Babesia sp. BQ1
(Lintan) using a QIAamp DNA Blood Kit (QIAGEN,
Maryland, USA) according to the manufacturer’s in-
structions. These DNA samples were used as the tem-
plates for PCR. The oligonucleotide primers that were
used to amplify the full-length and C-terminal-truncated
rap-1a61-1 genes were designed based on the DNA se-
quence of Babesia sp. BQ1 (Lintan) RAP-1a61-1 (Gen-
Bank accession number KC953701) and modified to
include either Xba I and BamH I or Nde I and Hind III
(New England BioLabs) enzyme restriction sites (under-
lined below) at their 5' end. The following primers were
used: RAP-1a61-full-F: 5'-CGC TCT AGA -GT ACG CCA
TTA CCA CCG TTC-3', RAP-1a61-full-R: 5'-GCC GGATCC
GAG CCA CGA ATC ATC GGA TTC-3', RAP-1a61/CT-
F: 5'-CGC CATATG ACC ACG GTG ATG CCC GAG-3',
and RAP-1a61/CT-R: 5'-GCC AAG CTT GAG CCA CGA
ATC ATC GGA-3'. The PCR products were cloned into
the pUC57 vector according to the manufacturer’s instruc-
tions (Genscript). The inserts were sequenced using vector
primers. Representative plasmids were selected and
digested using either Xba I and BamH I or NdeI and Hin-
dIII restriction enzymes and subsequently cloned into
digested pET-30a expression vectors (Genscript) according
to the manufacturer’s instructions. This resulted in the
generation of the recombinant plasmids pET-30a-RAP-
1a61-1 and pET-30a-RAP-1a61-1/CT, which contained the
full-length gene (1359 bp, except for signal peptide se-
quence) and the C-terminal-truncated fragment
(450 bp), respectively. Both of the cloned RAP-1a
proteins were tagged with histidine.
Expression and purification of the recombinant proteins
To express the recombinant proteins, both pET-30a-RAP-
1a61-1 and pET-30a-RAP-1a61-1/CT were transformed
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into BL21 E. coli (DE3 strain) cells. The expression of the
His-tagged fusion proteins rRAP-1a61-1 and rRAP-1a61-
1/CT was induced in the presence of kanamycin (50 μg/
ml) by adding 1 mM IPTG and then culturing the cells at
15 °C for 16 h. The bacterial cultures were harvested and
lysed using ultrasonication in binding buffer (50 mM Tris,
6 M Gu-HCl; pH 8.0) containing phenylmethylsulfonyl
fluoride (PMSF) and then purified as inclusion bodies from
the E. coli cells. The target protein was then eluted using
urea followed by a series of buffers containing increasing
concentrations of imidazole (200 mM, 500 m mM and
2500 m mM). After the proteins were renatured, they were
suspended in 1× SDS-PAGE sample loading buffer
(62.5 mM Tris-HCl [pH 6.8], 2 % SDS, 5 % β-
mercaptoethanol, 10 % glycerol, and 0.02 % bromophenol
blue) and boiled for 5 min. The samples were briefly centri-
fuged prior to being separated using SDS-PAGE. Recom-
binant protein expression was then analyzed using Western
blot analysis.
Preparation of anti-rRAP-1/CT specific rabbit immune serum
New Zealand Rabbits (2 kg each) were subcutaneously
injected with 400 μg of purified rRAP-1a61-1/CT pro-
tein that had been emulsified in Freund’s complete adju-
vant (FCA, Sigma). In the negative control, the sera
were collected from each rabbit prior to the first injec-
tions. Booster injections contained the same amount of
protein in Freund’s incomplete adjuvant (FIA, Sigma).
These injections were administered on days 15, 20 and
28. The sera were collected from the immunized rabbits
15 days after the last injection, purified and stored at
-20 °C until further use.
Western blot analysis
Approximately 20 μg of purified Babesia sp. BQ1 (Lintan)
recombinant proteins (rRAP-1a61-1 and rRAP-1a61-1/
CT) were separated using SDS-PAGE in 18 % polyacryl-
amide gels. The proteins were transferred to nitrocellulose
(NC) membranes with a 0.45 μm pore size (BioRad) at
24 V and 50 W for 35 min. The membrane was then cut
into 0.25 cm strips and incubated in a blocking solution
[5 % skimmed milk powder in Tris-buffered saline
(pH 7.6) with 0.1 % Tween-20 (TBST)] for approximately
3 h at 4 °C on a shaker. After the NC strips had been
washed three times, they were incubated for 1 h with each
tested serum (diluted at 1:100 in TBST). After the strips
were washed three times in TBST, they were incubated for
2 h with monoclonal anti-goat/sheep IgG-alkaline phos-
phatase conjugates (Sigma, A8062, dilution: 1:5000). The
strips were then washed three times with TBST and
incubated in a 5-bromo-4-chloro-3-indolyl phosphate/
nitro blue tetrazolium (BCIP/NBT) liquid substrate
system (B1911-100ML, Sigma) for 15 to 20 min. The
approximate molecular weights of the revealed proteins
Fig. 1 The geographical distribution of the B. motasi-like sp. that was identified in this study and the distribution of Haemaphysalis spp. in China.
The positive rates exceed 50 % indicated with deep red, and the positive rates ranged from 20 to 40 % indicated with light red, less than 10 %
infected rates indicated without color
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were evaluated by comparing their migration to a standard
molecular weight marker (SM0671, 10–170 kDa, PageRuler
Prestained Protein Ladder; SM1861, 1.7–40 kDa, Spectra
Multicolor Low Range Protein Ladder, Thermo Scientific).
IFAT and confocal laser microscopic observation
An immunofluorescence analysis was performed using a
procedure previously described by Moitra et al. [39] with
rabbit antiserum directed against rRAP-1a61-1/CT. The
iRBC membrane was stained using a PKH26 red fluores-
cent cell membrane labeling kit (MINI26, Sigma-Aldrich)
according to the manufacturer’s instructions. The iRBCs
were fixed in a buffer containing 4 % paraformaldehyde
and 10 mM piperazine-N, N-bis (2-ethanesulfonic acid) in
PBS (PIPES) at pH 6.4 on 22 mm2 poly-L-lysine-coated
coverslips for 30 min at room temperature. The coverslips
were washed in PBS and then blocked for 1 h in 3 %
bovine serum albumin (BSA) in PBS containing 0.25 % Tri-
ton X-100. The coverslips were stained overnight at 4 °C
with either pre-immune serum or purified anti-rRAP-
1a61-1/CT serum (1:50) diluted in blocking buffer without
Triton X-100. The coverslips were washed 3 times in PBS,
stained for 1 h with FITC-conjugated anti-rabbit IgG
(whole molecule) secondary antibodies (Sigma: F0382;
1:80), and then washed 3 times in PBS. The coverslips were
stained with 1 μg/ml 4’,6-diamidino-2-phenylindole (DAPI)
(Sigma: D8417) for 10 min and then examined for reactiv-
ity using confocal microscopy.
ELISA
The optimum concentration of coating buffer (0.1 M car-
bonate/bicarbonate, pH 9.6) was determined for rRAP-
1a61-1/CT (100 μl at 2 μg/ml). It was then distributed and
adsorbed in 96-well flat-bottom microplates at 4 °C over-
night. After three washes with PBST (0.1 % Tween-20), the
plates were blocked with 200 μl of 2 % gelatin in PBST at
37 °C for 1 h. After the plates were washed, the positive
and negative sera (dilution: 1/100) were distributed in du-
plicate, and the plates were incubated for 1 h at 37 °C. After
the plates were washed 3 times, 100 μl of monoclonal anti-
goat/sheep IgG-peroxidase (Sigma, A9452, dilution: 1:1000)
was added to each well, and the wells were incubated for
1 h at 37 °C. After the plates were washed another 3 times,
100 μl of 1-Step™ Ultra TMB-ELISA (34028–250 ml,
Thermo Scientific) was added to each well, and the plates
were incubated for 15 to 25 min at room temperature. The
reaction was stopped by adding 100 μl of 2 M H2SO4, and
the plates were read at 450 nm using an ELISA automat
(Bio-Rad Model 680 microplate reader, USA).
Statistical analysis
The 95 % confidence intervals (95 % CIs) for the overall
prevalence values of Babesia sp. BQ1 (Lintan) infection
were calculated using IBM SPSS Statistics version 19.0.
Results
Cloning and expression of RAP-1a61-1 and C-terminal-
truncated RAP-1a61-1
The genes encoding RAP-1a61-1 (aa 22-474) and C-
terminal RAP-1a61-1/CT (aa 325-474) (aa sequence
corresponding to GenBank accession number AGV15809)
were successfully amplified using PCR and inserted into
the cloning vector pUC57. The pET-30a-RAP-1a61-1 and
pET-30a-RAP-1a61-1/CT recombinant plasmids were
identified using enzyme restriction analysis (Sac I/Sal I
and Mlu I/Hind III, respectively) and confirmed by
sequencing using specific primers. The insert sequences
were also verified (data not shown). After the expression
of each recombinant protein was induced using IPTG,
the E. coli lysates were analyzed using SDS-PAGE and
Western blot analysis of an anti-His serum. The results of
SDS-PAGE showed that rRAP-1a61-1 and rRAP-1a61-1/
CT were expressed as proteins that were approximately
52 kDa and 20 kDa in size, respectively (Fig. 2).
Evaluation of the specificity of rRAP-1a61-1 and
rRAP-1a61-1/CT using Western blot analysis
The reactivity of each positive serum that was obtained
from infected sheep with rRAP-1a61-1 and rRAP-1a61-
1/CT was analyzed using Western blot analysis. Strong
reactions showing an expected size of rRAP-1a61-1/CT
(approximately 20 kDa) were observed in the positive
sera obtained from sheep infected with Babesia sp. BQ1
(Lintan) (No. 3216), Babesia sp. BQ1 (Ningxian) (No.
08026) and Babesia sp. Tianzhu (No. 08040). In con-
trast, no reaction was observed between rRAP-1a61-1/
CT and sera obtained from sheep infected with Babesia
sp. Hebei (No. 08020) and Babesia sp. Xinjiang (No.
3201) (Fig. 3). Furthermore, cross-reactivity between the
full-length rRAP-1a61-1 protein and sera from Babesia
sp. Xinjiang-infected sheep and B. bigemina-infected cat-
tle was also observed (data not shown).
Identification of native RAP-1 proteins using Western blot
analysis and IFAT
To identify native RAP-1 in Babesia sp. BQ1 (Lintan)
merozoites, antibodies against the C-terminal-truncated
recombinant RAP-1a61-1/CT were obtained from rab-
bits and the positive serum obtained from animals in-
fected with Babesia sp. BQ1 (Lintan) (No. 3216), and
the RAP-1a61-1 protein was detected at approximately
52 kDa in the lysates of Babesia sp. BQ1 (Lintan)-in-
fected sheep erythrocytes (Fig. 4). No specific reaction
was observed in Western blot analyses between the sera
with the lysates of uninfected sheep erythrocytes (data
not shown).
The IFAT results showed that the merozoite nucleus of
parasites were stained with DAPI and FITC-conjugated
anti-rabbit IgG is able to detect anti-rRAP-1a61-1/CT
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antiserum. The immunofluorescence signals are the result
of the interaction between the serum from a rabbit that
was immunized by rRAP-1a61-1/CT and Babesia sp. BQ1
(Lintan) merozoites. Specific fluorescent signaling was not
detected using pre-immune rabbit serum (Fig. 5).
Cross-reactivity with other hemoparasites using ELISA
Positive sera against Babesia sp. BQ1 (Lintan), Babesia
sp. BQ1 (Ningxian), Babesia sp. Tianzhu, Babesia sp.
Hebei, Babesia sp. Xinjiang, T. lunwenshuni, T. uilen-
bergi, A. ovis, B. bovis, and B. bigemina were tested using
ELISA to evaluate cross-reactivity with rRAP-1a61-1/
CT. The tests were repeated in triplicate, and the
specific antibody mean rate (AbR % = (Sample mean
OD-Negative control mean OD)/(Positive control mean
OD-Negative control mean OD) × 100) and standard
deviation were calculated using Excel 2007 [38]. The re-
sults indicated that cross-reactivity was observed only
between three B. motasi-like isolates (Lintan, Tianzhu
and Ningxian) and that no cross-reactivity was observed
with the sera against Babesia sp. Hebei, T. lunwenshuni,
T. uilenbergi, B. bovis, B. bigemina or A. ovis (Fig. 6).
The kinetics of anti-Babesia sp. BQ1 (Lintan) antibodies
were tested in experimentally infected sheep using ELISA
The kinetics of antibodies produced against RAP-1a
have been studied using ELISA with rRAP-1a61-1/CT in
sera collected from 5 intact infected sheep (Nos. 3216,
2007, 3390, 3533 and 3446) before (0 weeks post-
infection, WPI0) and after infection (from WPI1 to
WPI12). A significant increase in the amount of anti-
bodies produced against RAP-1a was observed after the
sheep were infected, but varying kinetics were observed
between individual sheep. In two of the Chinese sheep
(Nos. 3216 and 2007), antibody production against RAP-
1a was increased during the early phase of infection, at
1–3 weeks (WPI1-3), after which it decreased. In con-
trast, a gradual increase in the number of antibodies
produced against RAP-1a was observed in the three
French sheep (Nos. 3390, 3533 and 3446). Higher anti-
body levels were observed at 6–7 weeks post-infection
(WPI6-7) in sheep Nos. 3390 and 3446 and at 9 weeks
(WPI9) in sheep No. 3533. In general, antibodies were
produced at 1 week post-inoculation, continued to in-
crease through 6 weeks (WPI6), and remained stable
Fig. 2 SDS-PAGE and Western blot analysis of the purified rRAP-
1a61-1 (Panel a and b) and C-terminal truncated rRAP-1a61-1/CT
(Panel c and d) proteins with His-tags that were expressed in E. coli
cultures. M: molecular weight marker. Lanes 1 and 3: SDS-PAGE analysis;
Lanes 2 and 4: Western blot analysis using an anti-His antibody
Fig. 3 Western blot analysis of the recombinant RAP-1a61-1/CT protein in Babesia sp. BQ1 (Lintan). M: molecular weight marker. Lanes 1 and 2:
positive sera for Babesia sp. BQ1 (Lintan) (WPI3 and 4); Lanes 3 and 4: positive sera for Babesia sp. Tianzhu (WPI3 and 4); Lanes 5 and 6: positive
sera for Babesia sp. BQ1 (Ningxian) (WPI3 and 4); Lanes 7 and 8: positive sera for Babesia sp. Hebei (WPI3 and 4); Lanes 9 and 10: positive sera for
Babesia sp. Xinjiang (WPI3 and 4); Lanes 11-13: positive sera for B. bigemina, B. bovis and T. luwenshuni; and Lane 14: pre-immunized sheep (No. 3216)
sera were used as the negative controls
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until 9 weeks (WPI9), after which slight decreases were
observed through 12 weeks (WPI9-12). High levels of
antibodies against RAP-1a usually lasted 3 months
(84 days p.i.), despite the decrease in production that
was observed after 6 weeks (42 days p.i.) (Fig. 7).
Evaluation of specificity, sensitivity and positive threshold
values in ELISA to detect rRAP-1/CT
MedCalc statistical software was used to evaluate the
sensitivity, specificity, and positive threshold value in
ELISAs performed to test 191 positive sera and 492
negative sera, as previously described [40]. A percentage
corresponding to the specific antibody mean rate
(AbR %) was calculated for each serum sample. The
results indicated that the threshold value was 18.84 %,
which corresponded to 94.8 % sensitivity (95 % CI = 82.4–
98.4) and 96.1 % specificity (95 % CI = 85.1–99.4). The
numbers of false positive and false negative sera were 10
and 15, respectively (Fig. 8).
ELISA identification of the rRAP-1a61-1/CT protein as a
potential antigen for use in serological epidemiology in
B. motasi-like sub-group (Lintan, Ningxian and Tianzhu
isolates) infections
Field serum samples were extracted from a total of 3198
sheep and goats from 54 different regions of 23 Chinese
provinces. The samples were analyzed using ELISA to
evaluate the prevalence of infection with B. motasi-like
Fig. 4 Western blot analysis of native RAP-1 in Babesia sp. BQ1
(Lintan) merozoite lysates. Lysates from Babesia sp. BQ1 (Lintan)-
infected sheep erythrocytes were recognized by the serum of a
rabbit that was immunized using rRAP-1a61-1/CT. Positive serum from
Babesia sp. BQ1 (Lintan) (No. 3216) (Lanes 1 and 2). Pre-immunized
sheep (No. 3216) and rabbit sera (Lanes 3 and 4) were used as the
negative controls
Fig. 5 Identification of native RAP-1 proteins on Babesia sp. BQ1 (Lintan) parasites using immunofluorescence analysis. Babesia sp. BQ1 (Lintan)-
infected red blood cells were stained with rabbit pre-immune serum (control) and anti-RAP-1a61-1/CT antibodies. RBCs were stained with PKH26
(shown in red). An anti-RAP-1a61-1 antibody (green) reacted with native RAP-1a on merozoites. Nuclei were counterstained with DAPI (blue).
Merged images are shown to the right. Arrowheads indicate the merozoites. Scale-bars: 7.5 μm
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(Lintan, Ningxian and Tianzhu) isolates in these regions.
The results of ELISA detection to identify positive sam-
ples are summarized in Table 1. Sero-positive with B.
motasi-like were identified in 51 regions covering all 23
surveyed provinces. The total positive rate in these
regions was 36.02 % (95 % CI = 33.7–68.4). The sero-
prevalence ranged from 2.22 to 81.11 %. The signifi-
cantly high positive rates exceeded 50 % in 7 of the 23
surveyed provinces, including Liaoning (50 %), Inner
Mongolia (61.01 %), Shaanxi (75.68 %), Hunan (52.73 %),
Sichuan (59.72 %), Anhui (81.11 %) and Shanxi (58 %).
Three additional provinces, including Qinghai (45.35 %),
Ningxia (49.38 %) and Guangdong (41.89 %), had positive
rates exceeding 40 %. Lower sero-prevalence was observed
in Tibet (2.22 %), Jilin (7.55 %) and Guangxi provinces
(9.74 %). Positive rates that were greater than 80 % were
observed in Chifeng (86.15 %) in Inner Mongolia and
Lintan (83.33 %) in the Gansu provinces (Table 1, Fig. 1).
Discussion
In the genus Babesia, RAP-1 was initially described
according to its recognition by monoclonal antibodies to
merozoite antigens in B. bigemina. It was designated p58
at that time [41], and it was subsequently identified in all
Babesia species that were examined. The sequence of the
full-length rap-1 gene was first published in B. bovis
(named pBv60) [18], and the sequence and multigene
nature of p58 (later named rap-1a) were described in B.
Fig. 6 The cross-reactivity of rRAP-1a61-1/CT from Babesia sp. BQ1 (Lintan) with positive sera against Babesia-, Theileria- and Anaplasma-infected
sheep or cattle was determined using ELISA. LT: Babesia sp. BQ1 (Lintan), TZ: Babesia sp. Tianzhu, NX: Babesia sp. BQ1 (Ningxian), HB: Babesia sp.
Hebei, XJ: Babesia sp. Xinjiang, T.l: T. luwenshuni, T.u: T. uilenbergi, A.o: A. ovis, B.bi: B. bigemina and B. bo: B. bovis
Fig. 7 Kinetics of anti-Babesia sp. BQ1 (Lintan) antibodies in 5 sheep (Nos. 3216, 2007, 3446, 3390 and 3533) that were experimentally infected.
The error bars indicate the standard deviations, and the bold dotted line shows the mean AbR that corresponded to each time point
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bigemina [42]. The name RAP-1 was first applied when B.
bovis pBv60 was found to be localized in rhoptries under
immunoelectron microscopy [27]. The definitive structure
of the rap-1 locus was initially defined in B. bovis [43] and
then in B. bigemina [44]. In summary, an antibody react-
ing with a B. bigemina protein (p58) that was later identi-
fied as rap-1 was reported before its B. bovis homologue,
and the sequence features, the association of these pro-
teins with rhoptries, and the detailed organization of the
locus containing rap-1 were initially described in B. bovis.
In all studied Babesia species, the RAP-1 proteins share
common conserved features that include the strict conser-
vation of 4 cysteine residues, a highly conserved 14 amino
acid motif and several shorter conserved oligopeptide mo-
tifs in the first N-terminal 300 amino acids. Among babe-
sial parasites, the N-terminal regions of RAP-1 are more
conserved than those in the C-terminal region [32, 35].
In bovine Babesia species, previous studies have indi-
cated that the full-length recombinant RAP-1a in B.
bovis could be used as a diagnostic antigen in ELISA to
detect antibodies and to show cross- reactivity with
B. bigemina because of the conserved features in the
N-terminus of RAP-1, as described above [29]. In
contrast, RAP-1 B-cell epitopes in B. bovis and B.
bigemina have been mapped using monoclonal anti-
bodies and immune sera obtained from cattle, and
the results demonstrated that the B-cell epitopes pri-
marily targeted the C-terminal region of the proteins
[27, 45, 46]. Moreover, an ELISA based on recombin-
ant RAP-1a that is modified in the C-terminal region
has been developed to improve its sensitivity and spe-
cificity for antibody detection and could be widely
used as an antigen for serodiagnosis and epidemio-
logical survey purposes [37, 47–50]. In B. motasi-like
isolates, software prediction of RAP-1a B-cell epitopes
demonstrated that B-cell epitopes were also located in
the C-terminal region. Only a few B cell-epitopes
were predicted in the N-terminal region (data not
shown). Interestingly, the amino acid sequences be-
tween RAP-1a61 and RAP-1a67 are more conserved
at the C-terminal region than the N-terminal region
in B. motasi-like [34], which is not consistent with
the common features described above. Moreover, the
sequences of RAP-1a and the full rap-1 locus, includ-
ing the intergenic regions in three isolates (Lintan,
Ningxian and Tianzhu) of B. motasi-like, were almost
identical [12]. The features of the more conserved C-
terminal region of the RAP-1a protein in B. motasi-
like could indicate that this form is an ideal candidate
for diagnostics aimed at identifying several B. motasi-
like isolates.
The sera were able to recognize the native RAP-1 pro-
tein in Western blot analysis and IFAT, suggesting that
the sheep had been immunized against RAP-1 during
infection. Significant cross-reactivity was observed be-
tween rRAP-1a61-1/CT of Babesia sp. BQ1 (Lintan) and
the positive sera obtained from Babesia sp. Tianzhu and
Babesia sp. BQ1 (Ningxian) in both Western blot ana-
lyses and ELISA, but not in the Hebei isolate. This is not
surprising because the rap-1a sequences were almost
identical in these three Babesia isolates at both the nu-
cleotide and amino acid level. In contrast, the sequences
of all of the rap-1 genes obtained from Babesia sp.
Hebei were clearly different from the other 3 isolates,
suggesting that this isolate might belong to a different
species [12]. These findings were inconsistent with a
previous study that indicated that weak cross-reactivity
between Babesia sp. BQ1 (Ningxian) and Babesia sp.
BQ1 (Lintan) was detected using Western blot analysis
but not ELISA using a merozoite antigen (BQMA) [40].
Some novel antigens (e.g., BQP35 and BQHsp90) for
Babesia sp. BQ1 (Lintan) were recently identified as can-
didate diagnostic antigens. Western blot analysis and
ELISA tests that are based on BQP35 have shown that
there is cross-reactivity between Babesia sp. BQ1 (Lintan)
and Babesia sp. Tianzhu, which is in agreement with the
results obtained when merozoite extracts were used [51].
However, rBQHSP90 could not differentiate between any
B. motasi-like isolates and Babesia sp. Xinjiang, another
distinct ovine Babesia species [52]. Differences in cross-
reactivity have been observed when using the ELISA
method based on BQP35, BQHsp90 or RAP-1a of Babesia
sp. BQ1 (Lintan), and these might be caused by differences
in molecular characterizations and the detection limita-
tions and sensitivities of these antigens. These findings
suggest that rRAP-1a61-1/CT could be used as a poten-
tially diagnostic antigen to increase the sensitivity and spe-
cificity of such tests, and that it might replace native crude
parasite antigens, which require parasite reproduction
(from the killing of experimentally infected animals) or
the in vitro harvesting of cultures [53, 54].
Fig. 8 Evaluation of the specificity, sensitivity and positive threshold
value of rRAP-1/CT in ELISA using antibody mean rates (AbRs) for
positive and negative sera. 0 = negative sera, and 1 = positive sera
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Table 1 Prevalence of Babesia sp. BQ1 Lintan in field samples collected from 23 provinces by detected antibodies produced from
rRAP-1a CT with ELISA
Province Prefecture No. of sera No. of positive sera Positive rate (%) in different
regions
Positive rate (%) in each
province
Qinghai Haibei 269 122 (122/269) 45.35
Xinjiang Yili 229 82 35.81 (118/419) 28.16
Akesu 90 20 22.22
Habahe 100 16 16
Gansu Jingtai 120 8 6.67 (160/447) 35.79
Jiayuguan 81 6 7.41
Tianzhu 81 56 69.14
Yongchang 75 15 20
Lintan 90 75 83.33
Tibet Lhasa 90 2 (2/90) 2.22
Liaoning Huanren 29 14 48.28 (42/84) 50
Anshan 27 10 37.04
Fengcheng 28 18 64.29
Jilin Yongji 26 3 11.54 (4/53) 7.55
Jiutai 27 1 3.70
Inner Mongolia Ordos 63 21 33.33 (133/218) 61.01
Manzhouli 13 0 0
Baotou 12 0 0
Chifeng 130 112 86.15
Shaanxi Yulin 74 56 (56/74) 75.68
Ningxia Wuzhong 81 40 (40/81) 49.38
Guangxi Jingxi 35 3 8.57 (15/154) 9.74
Tianyang 56 10 17.85
Pingxiang 18 0 0
Guilin 45 2 4.44
Hunan Xinhuang 29 16 55.17 (29/55) 52.73
Xiangtan 26 13 50
Sichuan Panzhihua 36 25 69.44 (43/72) 59.72
Hejiang 36 18 50
Yunnan Fuyuan 35 2 5.71 (65/202) 32.18
Honghe 32 16 50
Jinghong 20 5 25
Yanshan 34 10 29.41
Menghai 12 3 25
Ruili 32 14 43.75
Kunming 37 15 40.54
Anhui Hefei 90 73 (73/90) 81.11
Guangdong Zhaoqing 38 20 52.63 (31/74) 41.89
Lianzhou 36 11 30.56
Guizhou Dushan 30 1 3.33 (46/166) 27.71
Ziyun 32 13 40.63
Yuping 32 19 59.38
Guiyang 72 13 18.06
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The kinetics analysis revealed that the humoral im-
mune response to this parasite varied in different sheep
breeds (Chinese and French sheep) during the course of
infection. This result was inconsistent with a previous
study that used BQMA and indicated that there is no
difference in kinetics between these two sheep breeds
[38]. Antibody production against RAP-1 was initially in-
creased in the two infected Chinese sheep between
WPI1 and WPI2, but it then decreased. These results
were consistent with the findings of a recent study, in
which a RAP-1a peptide designed from the RAP-1a N-
terminal of Babesia sp. BQ1 (Lintan) was used as an
antigen to perform ELISA. Antibody production against
this peptide displayed kinetics that were similar to those
observed against rRAP-1a61-1 (data not shown). In con-
trast, the production of specific antibodies against Babe-
sia sp. BQ1 (Lintan) in the three infected French sheep
was increased at three weeks post-infection and peaked
between six and nine weeks post-infection. On average,
RAP-1a was expressed at sequentially higher levels from
week 1 to week 7 post-infection before its levels subse-
quently decreased. The difference in the kinetics of anti-
body production between these five infected sheep might
result from differences in sheep breeds or individual vari-
ation. In general, our results are similar to those described
in a previous study that used a merozoite antigen (BQMA)
to evaluate the kinetics of antibody production during the
course of Babesia sp. BQ1 (Lintan) infection. That study
showed that antibody production was decreased from
WPI 12 (approximately 80 DPI) [38].
A serological diagnostic test (ELISA) is the most prac-
tical and economical assay for a wide range of epidemio-
logical investigative purposes, and it has been established
as a method for evaluating the lysates of Babesia-infected
erythrocytes in a number of Babesia species [55]. How-
ever, studies focusing on the development of a serological
diagnostic ELISA test that is based on recombinant
immune antigens that can detect ovine babesiosis are rare.
The development of ELISA tests requires preliminary
knowledge of parasite polymorphism, the ability to suc-
cessfully culture cells in vitro to produce antigens, and/or
prior genetic knowledge of the targeted antigen so that
specific sequences can be selected as an epitope. Some
improved ELISA methods for sero-epidemiological sur-
veys have been developed based on specific recombinant
proteins (RAP-1 and SBPs) that are involved in the RBC
invasion process in B. bovis, B. bigemina and B. caballi
species [36, 37, 50, 56]. In this study, the results of sero-
investigations using an ELISA method that was developed
based on the rRAP-1a61-1/CT protein indicated that
Babesia sp. BQ1 (Lintan), Babesia sp. BQ1 (Ningxian)
and Babesia sp. Tianzhu infections were identified in
all of the investigated provinces. Recent large-scale sero-
epidemiological ELISA surveys of Babesia sp. BQ1
(Lintan) were performed in small ruminants from 22
provinces of China, and these were also regions that
were tested in our study, and the results indicated
that infection by this isolate was identified in all 22
investigated provinces, with an average prevalence of
43.5 %. These values are slightly higher than the
values produced in our study and they showed a posi-
tive rate that was as high as 91 % in Inner Mongolia
[57]. The positive rates from 8 provinces that were
tested using rRAP-1a were slightly higher, whereas
the positive rates from 14 of the provinces were sig-
nificantly lower in our study than in a previous study
[57]. This variation may result from differences in the
limitations of the tested antigens. Moreover, another
Table 1 Prevalence of Babesia sp. BQ1 Lintan in field samples collected from 23 provinces by detected antibodies produced from
rRAP-1a CT with ELISA (Continued)
Province Prefecture No. of sera No. of positive sera Positive rate (%) in different
regions
Positive rate (%) in each
province
Chongqing Jiangjin 30 11 36.67 (15/53) 28.30
Wanzhou 23 4 17.39
Shandong Dongying 90 19 (19/90) 21.11
Shanxi Lvliang 50 29 (29/50) 58
Zhejiang Jingning 36 15 41.67 (32/117) 27.35
Qingtian 29 4 13.79
Hangzhou 52 13 25
Hubei Suizhou 81 27 (27/81) 33.33
Hebei Baoding 169 25 (25/169) 14.79
Henan Linzhou 60 20 33.33 (26/90) 28.89
Neihuang 30 6 20
Total 3198 1152 (1152/3198) 36.02
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sero-epidemiological investigation performed using
ELISA to detect infections in small ruminants by
Babesia species indicated that there was an average
infection rate of 82.38 % for Babesia sp. BQ1 (Lintan)
in 261 sera samples obtained from Lintan County in
Gansu province, and these result were similar to our
results (83.33 %) for this region [38].
The positive rates from 10 of the 23 provinces were
comparable to those found in a recent molecular detec-
tion study that used a nested PCR assay based on the rap-
1b gene of B. motasi-like species, the positive rates for
Babesia sp. BQ1 (Lintan), Babesia sp. BQ1 (Ningxian) and
Babesia sp. Tianzhu were 5, 13.8 and 21.9 % in Inner
Mongolia, Gansu and Xinjiang, respectively in this previ-
ous study (they were 61.01, 35.79 and 28.16 %, respect-
ively, in our study) [58]. No B. motasi-like infections were
detected in DNA samples obtained from the Zhejiang,
Guizhou, Chongqing and Liaoning provinces when the
nested PCR test was used [58]. Larger variation was
observed in the numbers of positive samples that were
identified in these provinces when ELISA was used in our
study. A similar study was performed that compared the
results of using ELISA (66.84 %) and the molecular LAMP
method (14.3 %) to analyze Babesia sp. BQ1 (Lintan)
infections in Gansu province [38]. Therefore, the differ-
ence in prevalence that is observed when using different
testing methods (e.g., PCR vs ELISA or LAMP vs ELISA)
or different antigens (e.g., BQMA vs rRAP-1a) or when
using the same method (e.g., ELISA) can be potentially
explained by the parameters that were used or the limita-
tions of the detection methods used in these assays.
Some studies have indicated that Haemaphysalis
qinghaiensis and H. longicornis are the vectors of the
Babesia sp. BQ1 (Lintan) isolate, while H. longicornis
has been proposed as the transmission vector for Babe-
sia sp. BQ1 (Ningxian). These two tick species are
widely distributed in at least 20 provinces of China
(Fig. 1) [4, 59, 60]. Whereas, the higher positive rates
(exceed 25 %) of B. motasi-like were found in Inner
Mongolia, Xinjiang, Hunan, Zhejiang, Guangdong and
Chongqing, as well as in Guangxi with positive rate of
9.74 % where the H. longicornis and H. qinghaiensis have
not been reported yet. This has been explained by sev-
eral possibilities by Wang et al. [57]. Moreover, cases of
ovine babesiosis have been reported in many Chinese
provinces, including Inner Mongolia, Henan, Shaanxi,
Yunnan, Sichuan, Heilongjiang and Qinghai province
[61–63]. Taken together, the results show that the wide
prevalence of the B. motasi-like isolates (Lintan, Ningxian
and Tianzhu) included in this study and co-infections
between these three isolates is not surprising, and these
isolates co-circulate in China with high prevalence. The
results suggest that the development of ELISA methods
that are based on the rRAP-1a61-1/CT described in our
study indicate that this ELISA is a potential diagnostic
method for epidemiological investigations of known
related isolates in addition to other unidentified isolates in
sheep B. motasi-like infections.
Conclusions
The present study demonstrates that antibodies against
rRAP-1a61-1 can detect native RAP-1 in Babesia sp.
BQ1 (Lintan) merozoite lysates in Western blot analysis
and IFAT. The high conservation of RAP-1a across the
three isolates from B. motasi-like parasites suggests that
rRAP-1a61-1/CT could be a promising common diag-
nostic antigen that can detect geographically distinct
isolates of B. motasi-like infections in sheep.
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